Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20190219003
TCTR20190219003
Not yet recruiting
未知

Adjunctive Corticosteroid Therapy for Pediatric Catecholamine-Dependent Septic Shock: A Pilot Study

Siriraj research development fund (managed by routine to research)0 sites80 target enrollmentFebruary 19, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCatecholamine&#45Dependent septic shockChildrenSeptic shockHydrocortisoneCorticosteroidsShock reversal

Overview

Phase
未知
Intervention
Not specified
Conditions
Catecholamine&#45
Sponsor
Siriraj research development fund (managed by routine to research)
Enrollment
80
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2019
End Date
December 31, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Siriraj research development fund (managed by routine to research)

Eligibility Criteria

Inclusion Criteria

  • •All children 6 months †18 years of age with septic shock who require vasoactive\-inotropic support in the pediatric IC

Exclusion Criteria

  • •â€¢Pre\-existing hypothalamic\-pituitary\-adrenal axis dysfunction
  • •â€¢History of long term corticosteroid use within 6 months or short term corticosteroid use within past 4 weeks
  • •â€¢History of etomidate or ketonazole use within past 7 days
  • •â€¢HIV infection
  • •â€¢Skin lesion described as purpura fulminans
  • •â€¢History of receiving vasoactive\-inotropic drugs \> 24 hours before enrollment
  • •â€¢Diabetes mellitus
  • •â€¢Blood sugar ≥180 mg/dL before enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Evaluation of Corticosteroid therapy in Childhood Severe Sepsis (Steroids in Paediatric Sepsis, StePS) - a randomised pilot study - Steroids in Paediatric Sepsis, StePSChildren with severe sepsis requiring mechanical ventilation presenting within 12 hours of onset. The majority of children will either have community acquired sepsis (most commonly meningococcal or pneumococcal disease) or post operative infection. Few patients will have additional co-morbidities.MedDRA version: 9.1 Level: LLT Classification code 10040047 Term: SepsisMedDRA version: 9.1 Level: LLT Classification code 10053840 Term: Bacterial sepsis
EUCTR2007-002788-28-GBSouthampton University Hospital NHS Trust90
Completed
Not Applicable
Relationship between corticosteroid therapy for cardiac sarcoidosis and ventricular arrhythmiaCardiac sarcoidosis
JPRN-UMIN000026782Kanazawa University50
Withdrawn
Not Applicable
Corticosteroids in Community-acquired PneumoniaCommunity-acquired Pneumonia
NCT01631916Hospital General de Niños Pedro de Elizalde
Completed
Not Applicable
Effect of corticosteroid adjunctive therapy on the clinical course and outcome of severe community-acquired pneumonia (CAP): a randomised, double-blinded studySevere community-acquired pneumoniaRespiratoryPneumonia
ISRCTN22426306Institute of Health Carlos III (Instituto de Salud Carlos III) (Spain)56
Completed
Not Applicable
Treatment with adrenocorticotropic hormone in idiopathic membranous nephropathyIdiopathic membranous nephropathyUrological and Genital DiseasesNephropathy
ISRCTN70791258Department of Nephrology, University Hospital in Lund (Sweden)30